Home page arrow Research lines

Research line 1

RL 1: Analysis of existing and emerging biomarkers in individualised CVD risk assessment

 

The overall goal of this Research Line is to develop the stroke component of EPIC-CVD providing the foundation for subsequent work studying individualised CVD assessment.

 

Research Line specific objectives:

 

to verify diagnoses of incident stroke in suspected cases;

 

to retrieve and prepare samples from the EPIC central store for identified stroke cases;

 

to assess the impact of 22 clinical chemistry biomarkers on risk of incident CVD

 

to coordinate the activities for designing the analysis of data collected in the EPIC-CVD project;

 

to supervise the preparation of analytical plans for the main analyses related to soluble biomarkers (WP3, RL2, RL3) and hereditary markers (WP10, WP11); and

 

to supervise the preparation of analytical plans for risk assessment.